Tornetta v. Musk — Entire Fairness and the Ratification That Could Not Cure, Seen from Switzerland
310 A.3d 430 (Del. Ch. 2024) — the rescission of the $55.8 billion Musk compensation package on entire-fairness review, and the subsequent ruling that a shareholder reconfirmation could not cure the process defect. Transposed to Swiss law, the case tests procedural architecture that Switzerland — since the 2023 stock-corporation reform — addresses ex ante through Art. 732 ff. OR, in a way the Delaware of 2018 did not.
Comparative-piece note
This commentary transposes a highly visible Delaware decision to the Swiss-law frame. Both sides deserve the author’s substantive verification: the Delaware reading is a first-pass of Chancellor McCormick’s January 2024 opinion and the December 2024 follow-on, and the Swiss transposition — particularly on whether the 2023 revised Art. 732 ff. OR architecture would reach the underlying process defects on comparable Swiss facts — reflects the author’s practice judgment and should be refined before public release.
Update — 19 December 2025. The Delaware Supreme Court overturned Chancellor McCormick’s rescission, restored Musk’s 2018 compensation package, and awarded nominal damages of one dollar. The reversal alters the Delaware-side outcome of the case but does not disturb the comparative point developed below: the underlying procedural defects identified by the Court of Chancery — committee alignment with the beneficiary, disclosure shortfalls, the controller’s shaping of the process — would have been constrained at the Swiss ex ante gates of Art. 732 ff. OR well before they could mature into the kind of dispute either court was asked to resolve. Readers wanting the DSC opinion’s detailed reasoning should consult the primary materials directly.
On 30 January 2024, Chancellor Kathaleen McCormick of the Delaware Court of Chancery rescinded the 2018 performance-based stock option grant to Elon Musk — a package that, on full vesting, had become by operation of Tesla’s market-cap appreciation the largest single executive compensation award in corporate history. The headline number — $55.8 billion — was the reason the decision made the front page of every business publication in the world. The reason it matters as a comparative-law artefact is different: the decision was decided not on the quantum but on the process, and the process arguments it turns on are arguments Swiss law, since the 2023 stock-corporation reform, increasingly handles ex ante through statute rather than ex post through fiduciary review.
The case
In early 2018, Tesla’s board of directors proposed a ten-year, twelve-tranche performance stock option grant to Elon Musk. Each tranche vested on the achievement of paired market-capitalisation and operational milestones; if all twelve tranches vested — a contingency few observers in 2018 considered plausible — the grant would deliver roughly 303 million options. The board submitted the package for shareholder approval; in March 2018, the package was approved by 73 per cent of disinterested shares (excluding Musk’s own roughly 22 per cent position and shares held by his brother). Tesla’s market capitalisation thereafter rose from approximately $60 billion to over $650 billion. All twelve tranches vested.
Richard Tornetta, a Tesla shareholder, filed a derivative action in the Court of Chancery shortly after the 2018 approval, alleging breach of fiduciary duty by the Tesla directors and by Musk as controller. The matter was tried before Chancellor McCormick; the January 2024 opinion rescinded the grant.
The holding — entire fairness
The core doctrinal move was the standard of review. Chancellor McCormick concluded that Musk exercised controller influence over the board, the compensation committee, and the process by which the grant was constructed — even though his equity stake was well below a majority. Under Delaware law, when a controller stands on both sides of a transaction (or benefits from a conflicted transaction the board considers), the transaction is reviewed not under the deferential business- judgment rule but under entire fairness, a substantially stricter standard that tests both fair dealing (the process) and fair price (the terms). The burden is on the defendants.
On fair dealing, the Chancellor found the compensation committee’s members had deep, long-standing personal or professional relationships with Musk; the “negotiations” were not arm’s-length; Tesla’s CFO and general counsel assisted Musk rather than the committee; and the committee did not meaningfully engage benchmarking or alternative structures. On fair price, the Chancellor found the quantum — the eventual $55.8 billion — was not supported by a clear record that the grant was necessary to retain Musk, who at the time had already committed enormous personal stakes in Tesla’s success.
The 2018 shareholder vote approving the package was not, in the Chancellor’s analysis, a cleansing event: the proxy disclosures had been materially deficient, and ratification obtained on incomplete disclosure does not cleanse a controller- conflict transaction under the standard established in Corwin v. KKR Financial Holdings LLC (Del. 2015) and its progeny.
Remedy: rescission. The grant was set aside.
The ratification that could not cure
In June 2024, Tesla’s shareholders voted again — this time on an explicit ratification of the 2018 grant, on the basis of revised disclosures. The ratification passed. Tesla argued to the Chancellor that this vote, properly informed, cured the original defects and that the grant should be reinstated. In a December 2024 ruling, the Chancellor declined to reinstate. The second vote, she held, could not cure the original fiduciary breach — the procedural architecture of the 2018 decision was not retroactively redeemable by a 2024 vote on a matter where the grant had already been performed, Tesla’s intervening reincorporation from Delaware to Texas did not displace the Delaware-law analysis of the underlying fiduciary defect, and the controller dynamics of the 2018 process were unchanged by the 2024 vote. On Tesla’s further appeal, the Delaware Supreme Court reversed on 19 December 2025, restoring the 2018 grant and awarding nominal damages of one dollar; the section above on Swiss law remains unchanged by that reversal, since the Swiss-law analysis engages the underlying compensation process, not the ultimate remedial outcome.
How Swiss law addresses the same facts — ex ante rather than ex post
A Swiss listed company proposing a compensation package of any scale to a CEO today operates within a procedural architecture that, on its own terms, would prevent the 2018 Tornetta fact pattern from recurring. The architecture is statutory and post-2023 — it codifies provisions that existed earlier as the VegüV ordinance and moves them, with important changes, into Art. 732–735c OR.
Art. 733 OR — mandatory compensation committee. Swiss listed companies must have a compensation committee elected by the shareholders; committee members are themselves subject to shareholder vote at each AGM. The committee’s independence from the CEO is structural, not merely aspirational.
Art. 735, 735a OR — mandatory binding shareholder vote. The aggregate compensation of the board and of the executive management must be approved by the shareholders at each AGM, separately. The vote is binding, not advisory, and the compensation to be disbursed in the following period cannot lawfully exceed what the shareholders approved.
Art. 735b OR — timing. The shareholder vote precedes the compensation period (prospective) or ratifies a following period (retrospective), depending on the company’s articles. In either case the vote frames the maximum envelope.
Art. 735c OR — prohibited structures. Swiss law categorically prohibits a defined set of compensation structures at listed companies: severance payments and payments contractually owed on termination; advance payments on future compensation; commissions or transaction-contingent bonuses paid on intra-group acquisitions and divestitures; loans and credits to directors and officers beyond defined limits; profit participations from group companies the beneficiary does not directly manage. A package of comparable scale that carried a termination-contingent cash component, or a transaction bonus paid on an intra-group M&A event, would breach these categorical prohibitions outright; the Musk 2018 grant itself was a performance-vesting equity package without those triggers and so would not, on its features, fall within the numerus clausus — which is the point: the prohibition regime removes by statute the payment categories most historically prone to controller-driven mischief, without categorically constraining performance alignment.
Art. 734 ff. OR — compensation report. Detailed compensation disclosures are mandatory and audited. Shareholders vote on the report. Proxy-vote advisers assess the report in depth.
The cumulative effect is that the specific Tornetta fact pattern — a compensation committee substantively aligned with the beneficiary, a proxy disclosure that did not surface that alignment, and a shareholder vote taken on that incomplete record — would be constrained at the Swiss procedural gates well before any court had occasion to apply a fairness standard. The compensation committee would have to be elected by the shareholders; the committee’s independence would be a live question at every AGM. The grant would have to fit within the aggregate compensation envelope approved by the shareholders; a grant without an envelope-disclosed ceiling is not compatible with the Swiss vote mechanism as currently practised. Specific grant features are prohibited outright (set out below).
This does not mean Swiss law would prevent a large or performance-oriented grant of comparable quantum. A Swiss listed board with a clean independent committee, a shareholder-approved aggregate envelope large enough to accommodate the grant, and full disclosure could, in principle, authorise performance compensation of a comparable order. What Swiss law does is impose procedural gates — ex ante — that Delaware, in 2018, reviewed only ex post through the entire-fairness standard. The Swiss architecture is, in this sense, the legislative answer to the Tornetta question: rather than ask a court to evaluate fair dealing and fair price after the fact, impose the procedural conditions that make fair dealing substantially more likely.
Where procedural failure could still occur in Switzerland
The Swiss gates are not perfect. Three routes remain by which a Tornetta-adjacent outcome could arise on a Swiss listed board.
Committee capture by a controller. Where a controller-shareholder exerts practical influence over which directors stand for election — through nomination rights, shareholder-agreement provisions, or informal coordination — the compensation committee may be formally independent but substantively aligned. Swiss law does not directly regulate the nomination process; it relies on shareholder democracy and the individual director’s Art. 717 OR duty.
Inadequate disclosure in the compensation report. If the report does not adequately disclose the controller’s role in the committee’s process, the shareholder vote rests on incomplete information. Swiss law provides remedies here — the Anfechtungsklage under Art. 706 OR can challenge the resolution within two months — and personal director liability under Art. 754 OR where disclosure failures caused the company damage.
Abuse of majority by a controller voting its own shares. Where a controlling shareholder votes its shares in favour of a resolution that substantively favours that controller at the expense of the company or the minority, the resolution is challengeable for abuse of majority under Art. 706 al. 2 ch. 3 OR. The Tornetta fact pattern — controller voting to approve a grant to the controller-adjacent CEO — would, on Swiss facts, test this doctrine directly. Direct Swiss Federal Supreme Court authority on abuse of majority specifically in controller-involved compensation votes is limited; the doctrine operates largely in the shadow of the Art. 706 challenge window without having been tested at the Federal Supreme Court on a Tornetta-scale controller compensation pattern.
None of these routes is as well-worn as Delaware’s entire- fairness review. Swiss doctrine in this area is thinner; much of what happens in Delaware litigation happens in Swiss ex-ante practice and so never reaches a courtroom. This is a feature, not a bug — the procedural gates are what keep the courtroom-test cases off the docket — but it does mean the Swiss post-hoc toolkit is less battle-tested, and in an unusual controller dispute, a Swiss court would be navigating with less case-law guidance.
Where the two systems converge and where they do not
Convergence. Both jurisdictions recognise that a compensation package to a CEO who substantially controls the board’s composition or agenda is not a garden-variety arm’s-length transaction. Both treat process — committee independence, benchmark analysis, quality of negotiation — as the most important axis of review. Both are sceptical of shareholder ratification where the original disclosure was materially incomplete.
Divergence. Delaware intervenes through the ex post entire-fairness standard, exercised by the Court of Chancery. Switzerland intervenes through the ex ante procedural architecture of Art. 732–735c OR, policed by mandatory shareholder vote and disclosure. The Delaware approach produces dramatic cases — Tornetta being the paradigm — because the underlying transactions have already happened. The Swiss approach produces fewer cases because the transactions do not reach the courtroom in that form. A determined controller can nevertheless find Swiss vulnerabilities — notably through committee capture and abuse-of-majority votes — but the doctrinal terrain is different.
What boards should take from it
1. Committee composition is the load-bearing question. Swiss listed company boards already operate under a structural expectation of an independent compensation committee. Tornetta is a reminder that independence is not a formal attribute to be verified at appointment; it is a live state of the committee in the specific decision. A committee that is technically independent but whose members have histories of alignment with the CEO on prior matters will be scrutinised on Swiss facts under Art. 717 and, depending on the resolution, under Art. 706 OR. See the executive- dismissal and compensation agenda.
2. The compensation report must disclose what a critical reader would ask. The Tornetta ruling on ratification turned on the disclosure deficit in the proxy materials. Swiss listed companies' compensation reports face their own audit and shareholder scrutiny; the Tornetta lesson is that disclosure should anticipate the difficult question the controller- skeptical reader would ask — about benchmarking sources, about negotiation posture, about the alternatives considered, about the controller’s role in the process — not merely cover the statutory minimum.
3. Controller boards should not assume ratification saves them. The December 2024 Delaware ruling — that a subsequent shareholder vote could not cure the original process defect — is not a universal principle, but it is a signal. A Swiss controller-involved board that assumes an Art. 735 OR binding shareholder vote, obtained on incomplete disclosure, cleanses a compensation arrangement otherwise open to Art. 706 abuse-of-majority challenge is relying on the wrong cure. The cleaner path is to get the process right the first time.
4. Size attracts scrutiny that is structurally different. A very large compensation package, even one procedurally clean, will attract engagement from institutional investors, proxy advisers (ISS, Glass Lewis, Ethos), and eventually (in listed Swiss companies) the pension- fund votes organised via ethos and the SIX listing engagement frameworks. Tornetta’s rescission was possible because the shareholders who voted in 2018 had not seen the full picture. Swiss boards proposing large packages should work on the assumption that engagement-sophisticated shareholders will form their view and publish their rationale before the vote.
Implications for the reference work
Director Duties under Swiss Law, at the section on the duty of loyalty, will be updated to include a discussion of controller-involved compensation transactions and the limits of shareholder- ratification cleansing under Swiss doctrine. The Agenda briefing on executive dismissal and compensation gains a cross-reference to this commentary at the failure-modes section — specifically on the committee-independence and disclosure-quality dimensions.
Primary sources
Delaware: Tornetta v. Musk, 310 A.3d 430 (Del. Ch. 30 January 2024) (Chancellor McCormick’s entire-fairness rescission opinion); the December 2024 follow-on ruling of the Delaware Court of Chancery on the post-rescission shareholder ratification (docket C.A. No. 2018-0408-KSJM, as reported); Corwin v. KKR Financial Holdings LLC, 125 A.3d 304 (Del. 2015) (on ratification-based business-judgment deference and its limits in controller transactions); Kahn v. M&F Worldwide Corp., 88 A.3d 635 (Del. 2014) (on the MFW framework for conditioning controller transactions for business-judgment review).
Swiss sources cited: Art. 732 ff. OR (compensation framework for listed companies, post-2023 reform), Art. 733 OR (compensation committee), Art. 734 ff. OR (compensation report), Art. 735, 735a, 735b OR (binding shareholder vote), Art. 735c OR (prohibited structures), Art. 706 OR (Anfechtungsklage, including abuse of majority under para. 2 ch. 3), Art. 717 OR (duty of loyalty), Art. 754 OR (director liability). Case cross-references are to opencaselaw.ch where the decisions are Swiss.